 |
Megestrol acetate |
|---|---|
| Trade Name | Megace |
| Orphan Indication | Patients with anorexia, cachexia, or significant weight loss (=/>10% of baseline body weight) and confirmed diagnosis of AIDS |
| USA Market Approval | USA |
| USA Designation Date | 1988-04-13 00:00:00 |
| Sponsor | Bristol-Myers Squibb Pharmaceutical Research Institute;2400 West Lloyd Expressway;Evansville, Indiana, 47721 |
